Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Factorial Study to Compare the Safety and Efficacy of Varying Combinations of GEN-003 and Matrix-M2 in Subjects With Genital HSV-2 Infection

NCT02114060 is registered in ClinicalTrials.gov with Genocea Biosciences, Inc. as lead sponsor.

NCT NCT02114060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Factorial Study to Compare the Safety and Efficacy of Varying Combinations of GEN-003 and Matrix-M2 in Subjects With Genital HSV-2 Infection
Lead sponsor
Genocea Biosciences, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2014
Completion date
February 29, 2016
Enrollment
310 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

genital herpes simplex type 2